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Background: Acute procedurally induced hemodynamic depression can occur after carotid angioplasty and stenting
(CAS). This study was performed to determine the frequency and risk factors for hypotension and bradycardia after the
CAS procedure.
Methods: The study reviewed clinical variables and angiographic data of all patients undergoing elective CAS with
neuroprotection during a recent 5-year period. Intravenous atropine was given selectively in cases of bradycardia (heart
rate <60 beats/min or a decrease of >20 beats/min). We further defined hemodynamic depression as bradycardia or
severe hypotension (systolic blood pressure fall >30 mm Hg). Frequency and potential risk factors for hemodynamic
depression were analyzed by logistic regression.
Results: During the study period, 416 patients (99% male; mean age, 74  11 years) underwent the CAS procedure. The
median degree of stenosis was 93% (range, 60% to 99%). The frequencies of post-CAS hemodynamic depression include
hypotension in 58 (14%), bradycardia in 112 (27%), or both in 21 (5%). All patients with bradycardia received
intraprocedural atropine, and all heart rates returned to the baseline level. Persistent hypotension occurred in 45 patients
(11%). Increased age was associated with CAS-induced bradycardia or hypotension. Adjusted risk factors associated with
hemodynamic depression include age >78 years (odds ratio [OR], 5.25; 95% confidence interval [CI], 2.32 to 15.25; P 
.01) and ejection fraction of <25% (OR, 3.25; 95% CI, 0.58 to 6.58; P  .02). CEA-related restenosis was associated with
a reduced risk of hemodynamic depression (OR, 0.21; 95% CI, 0.12 to 0.69, P  .001). Persistent hypotension after CAS
was associated with an increased risk of an adverse clinical event (44%, P  .001).
Conclusions: Hemodynamic depression, including hypotension and bradycardia, is frequent after CAS. However,
CAS-induced hemodynamic depression is rare in patients with postendarterectomy stenosis. Patients with compromised
ejection fraction and increased age are at a higher risk of presenting with CAS-induced hemodynamic instability, and
persistent hypotension after CAS is associated with an increased postprocedural complication rate. ( J Vasc Surg 2007;
46:846-54.)Carotid angioplasty and stenting (CAS) has become an
increasingly used treatment alternative in selected patients
with extracranial carotid occlusive disease. In contrast to a
traditional carotid endarterectomy (CEA), CAS has be-
come a preferred treatment strategy for many patients
owing to perceived advantages of less invasiveness and
discomfort related to the procedure. The Stenting and
Angioplasty with Protection in Patients at High Risk for
Endarterectomy (SAPPHIRE) trial also fueled the enthu-
siasm of this catheter-based treatment strategy because it
reported a lower incidence of stroke, death, and myocardial
infarction (MI) with CAS compared with CEA in high-risk
patients.1,2
Despite this increased enthusiasm for CAS by physi-
cians and patients, it is widely recognized that CAS is a
highly technical procedure that is associated with compli-
cations.3,4 Neurologic impairment such as stroke remains
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846the most feared complication of this procedure, and efforts
to reduce procedurally related cerebral embolization con-
stantly drive researchers to develop better neuroprotection
devices. Other procedurally related physiologic phenom-
ena that may influence the treatment outcome can also
occur, and hemodynamic depression consisting of brady-
cardia or hypotension has been reported after CAS at
incidence of 5% to 76%.5-13
Catheter-related instrumentation of the carotid bulb,
such as balloon dilatation, can trigger a series of neuronal
responses resulting in bradycardia and hypotension. In the
event that such a hemodynamic response becomes suffi-
ciently profound, perioperative cardiopulmonary and neu-
rologic adverse sequelae can occur.14,15
This study had a twofold objective: We examined the
incidence and outcome of hemodynamic instability in pa-
tients undergoing CAS at our institution and the clinical
variables associated with hemodynamic depression in pa-
tients undergoing this percutaneous intervention.
METHODS
Patients. The hospital records and clinic charts for all
patients who underwent percutaneous CAS from January
2002 to December 2006 were reviewed. All procedures
were performed by vascular surgery staff physicians at the
Michael E. DeBakey Veterans Affairs Medical Center, a
hospital affiliated with the Baylor College of Medicine. A
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stenting procedure to document a high-grade carotid ste-
nosis. Patients with symptomatic carotid stenosis of 60%
and asymptomatic carotid stenosis of 80% were included
in our CAS protocol.
Treatment indications were based on high-risk criteria
adapted from a consensus report as well as our previous
reports.4,16-18 Briefly, these criteria are various anatomic
considerations, which include high carotid bifurcation
(C2 level), contralateral carotid occlusion, presence of
tracheostomy, history of ipsilateral neck irradiation, prior
radical neck dissection, or CEA. Moreover, these high-risk
criteria include patients with one or more medical comor-
bidities, such as myocardial infarction or stroke in the
previous 3 months, steroid-dependent chronic obstructive
pulmonary disease (defined as forced expiratory volume in
1 second if less than 30% of predicted or less than 1 L/s),
and a left ventricular ejection fraction of 25% or as docu-
mented congestive heart failure (CHF) at New York Heart
Association functional classification stage III or IV.
Carotid artery stenting protocol. Technical details
of the CAS procedure were described previously.4,16-18
Briefly, the patient was given clopidogrel (75 mg/d; Plavix,
Sanofi-Aventis, Bridgewater, NJ) and aspirin (81 mg/d)
beginning 3 days before the intervention. An intravenous
antibiotic (cephazolin, 1 g) was given 30 minutes before
the procedure.
After a femoral artery access was established with local
anesthesia using 1% lidocaine, an aortic arch angiogram was
performed with power injection using a 5F pigtail catheter.
Selective carotid catheterization was next performed using
a 5F diagnostic catheter to delineate the carotid anatomy.
Intravenous (IV) anticoagulation was initiated with a 0.75-
mg/kg bivalirudin bolus, followed by an hourly infusion
rate of 1.75 mg/kg.
A guidewire exchange was performed with a 0.035-in
stiff Glidewire (Terumo, Elkton, Md), which was used to
cannulate the external carotid artery or its branches. The
groin introducer sheath and diagnostic catheter were next
removed, followed by placement of a 7F, 90-cm shuttle
sheath (Terumo) in the distal common carotid artery. The
tracking of the shuttle sheath over the guidewire in the
common carotid artery was facilitated by positioning
the stiff Glidewire in the external carotid artery.
A selective digital carotid angiogram was performed
through the side port of the shuttle sheath to delineate the
anatomy of the common, internal, and external carotid
arteries. Biplanar intracranial injections were done to doc-
ument the cerebral vasculature.
The carotid lesion was crossed with the distal protec-
tion device used in all cases in this series, which was de-
ployed in the distal internal carotid artery. Carotid balloon
angioplasty was not routinely performed before stenting,
and such a maneuver was only used when difficulty was
encountered during crossing the carotid lesion with the
neuroprotection device.
A self-expanding monorail stent then was tracked over
the distal protection device and deployed across the carotidstenosis. Poststenting balloon angioplasty was routinely
performed using a 5- or 6-mm-diameter angioplasty bal-
loon on the basis of the completion carotid angiogram.
Completion angiography, which included biplanar ca-
rotid and cerebral views to document vascular anatomy and
exclude cerebral thromboembolism, was then done. The
cerebral embolization protection device was deactivated,
and the guidewire along with the shuttle sheath were
removed. The groin puncture site was closed with a 6F
femoral closure device (Starclose, Abbott Lab, North Chi-
cago, Ill). At the completion of the carotid stenting, intra-
venous bivalirudin was discontinued. The patient was to
continue taking oral clopidogrel for 1 month and aspirin
therapy indefinitely.
Assessment for hypotension and bradycardia. All
CAS procedures were performed in the operating room
under local anesthesia with minimal sedation. Hemody-
namic status was monitored by a staff anesthesiologist, and
physiologic data were registered in an electronic anesthesia
record. A radial arterial catheter was placed for continual
hemodynamic monitoring during all CAS procedures.
Blood pressure, heart rate, and respiratory rate were re-
corded before, during, and after the procedure. Baseline
hemodynamic information was taken before any anxiolytic
premedication was administered.
After the CAS procedure, the patient was transferred to
the recovery room, where hemodynamic condition was
monitored continuously for another 6 hours. The patient
was next transferred to the inpatient ward, where vital signs,
including heart rate and blood pressure, were checked every
2 hours.
The number of patients experiencing episodes of hypo-
tension or bradycardia after the CAS procedure was re-
corded. We defined bradycardia as a decrease of heart rate
60 beats/min or a decrease from the baseline level of20
beats/min. An episode of hypotension was defined as a fall
in systolic blood pressure of30 mmHg. Persistent hypo-
tension is defined as a fall in systolic blood pressure for 1
hour or hypotension requiring continuous intravenous va-
sopressor administration.
The occurrence of CAS-induced bradycardia was
promptly treated with intravenous atropine in 0.5-mg in-
crements to a maximum of 1.5 mg. Atropine is not given
prophylactically in our clinical practice. Postoperative hy-
potension was treated with crystalloids in 500-mL incre-
ments to a maximum of 2000 mL, depending on the
patient’s cardiac function and the physician’s clinical assess-
ment. In the event of persistent hypotension that was
refractory to fluid resuscitation, intravenous dopamine was
given with a dosage of 3 g/kg/min and titrated to a
maximum of 10 g/kg/min. Additional measures such as
admission to the surgical intensive care unit (SICU) and
administration of other appropriate vasopressor agents
would also be initiated.
Outcome variables included all neurologic complica-
tions and non-neurologic adverse events. Neurologic com-
plications were classified as one of the following:
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neurologic deficit that resolved completely 24 hours;
2. A minor stroke, which was defined as a new neurologic
deficit that either resolved completely 7 days or in-
creased the National Institutes of Health (NIH) Stroke
Scale score by 3, or
3. A major stroke, which was defined a new neurologic
deficit that persisted 7 days and increased the NIH
Stroke Scale score by 4.19,20
Adverse clinical events include cardiopulmonary com-
plications, post-CAS renal insufficiency, access-site pseudo-
aneurysm, and hemorrhagic complication. The latter com-
plication was defined as major groin or retroperitoneal
bleeding that required operative evacuation or blood trans-
fusion. Adverse cardiac events included myocardial infarc-
tion on the basis of electrocardiogram tracing or cardiac
enzyme elevation, worsening or renal function, or clinical
signs of CHF.
Data analysis. Data analysis was performed using
standard statistical methods. Categoric variables were com-
pared by using the Fisher exact test, and continuous vari-
ables were evaluated by using analysis of variance and the
Student t test. Univariate comparison of unpaired contin-
uous data was done with the Mann Whitney U test, and the
Wilcoxon paired test was used to compare paired continu-
ous data. A multivariate binary logistic regression model
was used to assess the role of hemodynamic depression and
its relationship with relevant clinical risk factors and post-
CAS complications. In all analyses, we only considered
variables with 80% of the data present or recorded. A
risk-factor adjustment model was used to determine poten-
tial confounding effects of other baseline variables if they
appeared to differ between patients with and without he-
modynamic instability. All continuous values are repre-
sented as mean  SD, and correlations were considered
significant at the P  .05 level. Statistical analysis was per-
formed with SPSS 10.0 software (SPSS Inc, Chicago, Ill).
RESULTS
CAS procedures were done in 422 patients during the
study period. Six patients were excluded from the analysis
because of incomplete intraoperative hemodynamic data
due to monitoring equipment failure (n  4) and missing
postoperative hemodynamic data in the recovery room
(n 2). The remaining 416 patients (99% male; mean age,
74  11 years) were analyzed. The primary CAS technical
success rate was 98% (407 of 416). Treatment indication
with carotid stenting included high-risk medical comor-
bidities in 303 (73%), prior CEA in 96 (23%), previous
tracheostomy in 6 (1%), high carotid bifurcation in 47
(11%), and prior neck radiation or dissection, or both,
in 8 (2%).
Hemodynamic depression occurred in 191 patients
(46%). The mean duration of the CAS procedure was 39
14 minutes. There was no difference in the procedural
duration among those who developed hemodynamic insta-
bility and who those remained hemodynamically stableduring the stenting procedure. Among the patients with
hemodynamic depression, hypotension occurred in 58 pa-
tients (14%) and bradycardia in 112 (27%). Among the
those with bradycardia, 76 had a decrease in heart rate to
60 beats/min and 36 experienced a decrease in heart rate
of20 beats/min compared with the baseline value. Con-
comitant post-CAS bradycardia and hypotension devel-
oped in 21 patients (5%). The immediate onset of brady-
cardia, defined as the immediate onset of bradycardia after
carotid artery intervention, occurred in 117 patients (28%)
after carotid artery angioplasty or stent placement. Delayed
onset of bradycardia (1 to 16 hours after carotid interven-
tion) occurred in 16 patients (4%).
The 117 patients who developed intraprocedural bra-
dycardia received immediate intravenous atropine, which
effectively normalized the heart rate. Among the 79 pa-
tients (19%) who experienced hypotensive episodes, 32
episodes (41%) occurred intraoperatively, and delayed on-
set of hypotension developed in 47 patients (59%) at 1 to
14 hours after carotid stent placement. Thirty-eight (48%)
of the hypotensive patients responded appropriately to
medical treatment, which included fluid resuscitation or
vasopressor agent infusion, or both. Persistent hypotension
occurred in 45 (11%), and 22 (5%) required an overnight
stay in the SICU for blood pressure monitoring.
The baseline hemodynamic status and the length of
hospital stay were similar between the two groups (Table I),
and no difference was noted in the procedural variables
such as contrast usage or fluoroscopic duration. In contrast,
hemodynamic depression was less likely to develop in pa-
tients with prior ipsilateral CEA compared with those with
a primary carotid atherosclerotic lesion; similarly, no differ-
ence was noted when the presenting symptoms between
the two groups were compared. Both groups also shared
similar plaques characteristics and luminal diameters. Further-
more, a depressed ejection fraction (25%) was associated
with an increased incidence of hemodynamic depression (Ta-
ble II).
When the association between hemodynamic depres-
sion and CAS-related complications was examined, no dif-
ference was found between the patients with and without
hemodynamic instability. However, persistent hemody-
namic instability was associated with an increased incidence
of neurologic complications (Table III). More specifically,
the 30-day death rate in patients with and without persis-
tent hemodynamic depression was 4% and 1% (P  .05),
and the 30-day stroke and death rate in patients with and
without persistent hemodynamic depression was 7% and 2%
(P  .05). An increase in non-neurologic complications
was similarly noted in patients with persistent hypotension
compared with those who did not experience persistent
hypotension. Specifically, the non-neurologic clinical ad-
verse event rate was 44% in patients with persistent hemo-
dynamic depression, which contrasted sharply with the 3%
rate among those who did not experience persistent hemo-
dynamic depression.
Binary logistic regression analysis showed that patients
with persistent hemodynamic depression were at an in-
not sig
mber
mber
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2.67; 95% confidence interval [CI], 1.38 to 6.32; P .01)
and non-neurologic clinical adverse events (OR, 3.25; 95%
CI, 1.58 to 7.52; P  .02). No other clinical or radio-
graphic predictor was identified using a multivariate analy-
Table I. Baseline demographic, treatment indication, and
hemodynamic depression undergoing carotid angioplasty a
Patient characteristics*
Patien
dep
Age, y
Male gender
Baseline systolic blood pressure pre-CAS (mm Hg)
Baseline heart rate pre-CAS (beats/min)
CAS technical success
Hospital length of stay, d
CAS treatment indication
High-risk medical comorbidities
Prior ipsilateral CEA
Prior tracheostomy
High carotid bifurcation
Prior neck irradiation/dissection
Procedural variables
Fluoroscopic time, min
Contrast used, mL
Asymptomatic carotid lesion
Symptomatic carotid lesion
Stroke
Transient ischemic attack
Amaurosis fugax
CAS, Carotid angioplasty and stenting; CEA, carotid endarterectomy; NS,
*Continuous data are presented with the mean  SD; categoric data are nu
Table II. Clinical comorbidity and carotid plaque charact
undergoing carotid angioplasty and stenting
Patient characteristics*
Patients w
depress
Comorbidities/clinical variables
Coronary artery disease 1
Smoking 1
Hypertension 1
Diabetes mellitus 1
Chronic obstructive pulmonary disease
Hyperlipidemia 1
Renal insufficiency, creatinine 1.5 mg/dL
Low ejection fraction, 25
Prior stroke
Prior ipsilateral CEA
-blocker usage 1
Carotid lesion characteristics
Carotid stenosis, % 8
Carotid luminal diameter before CAS, mm 2
Carotid luminal diameter after CAS, mm 6
Stent diameter, mm 7
Lesion involves carotid bulb 1
Contralateral carotid occlusion
Ulcerated plaque
Calcified plaque
CAS, Carotid angioplasty and stenting; CEA, carotid endarterectomy; NS,
*Continuous data are presented with the mean  SD; categoric data are nusis for stroke, death, or clinical adverse events.Morphologiccharacteristics and anatomic location of the carotid plaque
were also not associated with the development of post-CAS
complications.
A logistic regressionmodel was also used to analyze risk
factors for CAS-related hemodynamic instability and to
edural variables of patients with and without
tenting
h hemodynamic
(n  191)
Patients without hemodynamic
depression (n  225) P
 8.4 73  7.4 NS
(98) 223 (99) NS
 23 154  26 NS
 14 74  13 NS
(98) 220 (98) NS
 1.2 1.3  1.1 NS
(73) 164 (73) NS
(3) 93 (41) .001
(2) 3 (1) NS
(12) 25 (11) NS
(2) 5 (2) NS
 8 18  11 NS
 25 179  28 NS
(67) 158 (70) NS
(15) 38 (17) NS
(11) 18 (8) NS
(7) 11 (5) NS
nificant.
(%).
cs of patients with and without hemodynamic depression
modynamic
 191)
Patients without hemodynamic
depression (n  225) P
5) 153 (68) NS
3) 194 (86) NS
1) 200 (89) NS
0) 126 (56) NS
0) 38 (17) NS
5) 198 (88) NS
9) 36 (16) NS
8) 31 (16) .005
8) 50 (22) NS
) 93 (41) .001
3) 175 (78) NS
8 88  9 NS
0.8 2.6  1.0 NS
1.3 6.8  1.2 NS
1.5 7.8  1.6 NS
8) 158 (70) NS
5) 32 (14) NS
5) 74 (33) NS
9) 68 (30) NS
nificant.
(%).proc
nd s
ts wit
ression
75
188
156
72
187
1.6
139
5
3
22
3
16
185
128
29
21
13eristi
ith he
ion (n
43 (7
58 (8
74 (9
15 (6
38 (2
62 (8
36 (1
60 (3
34 (1
5 (3
38 (7
6 
.5 
.7 
.6 
30 (6
29 (1
67 (3
55 (2
not sigadjust for other confounding risk factors, which is shown in
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increased adjusted risk for hemodynamic depression after
carotid stenting, low cardiac ejection fraction was associ-
ated with a 3.25-fold increased adjusted risk, and patients
with prior ipsilateral CEA were protected from developing
hemodynamic instability during carotid stent placement.
DISCUSSION
Hemodynamic alterations such as bradycardia or hypo-
tension are a well-recognized physiologic response during
catheter-based carotid artery intervention, but most of
these events are transient and self-limiting in nature.8-11
However, it has been reported that profound bradycardia
and hypotension associated with CAS can result in severe
hemodynamic instability that may lead to neurologic se-
quelae.21,22 Therefore, our understanding of the clinical
significance and potential predisposing factors of CAS-
related hemodynamic instability is critical in improving the
procedural safety and minimizing potential complications.
Table III. Association of persistent hemodynamic depress
Complications
Patients with persistent hem
depression (n  45), n
Neurologic complications 4 (9)
Transient ischemic attack 3 (7)
Major stroke 1 (1)
Minor stroke 0
30-day death 2 (4)
30-day stroke/death 3 (7)
Clinical adverse events 20 (44)
Cardiopulmonary 9 (20)
Renal insufficiency 3 (7)
Access site pseudoaneurysm 2 (4)
Hemorrhagic 6 (13)
NS, Not significant.
Table IV. Binary logistic regression model assessing the
risk of any hemodynamic depression in patients
undergoing carotid angioplasty and stenting
Factor OR 95% CI P
Age, y
65 1.02 0.85-6.52 .25
66-71 2.25 1.25-9.25 .21
72-77 2.36 1.35-10.52 .18
78 5.25 2.32-15.25 .01
Diabetes mellitus 1.58 1.25-3.68 .125
Prior stroke 2.36 1.25-8.67 .89
Symptomatic carotid lesion 0.89 0.58-5.25 .96
History of hypertension 1.36 0.26-6.47 .136
Renal insufficiency 1.34 0.82-5.17 .87
Hyperlipidemia 3.21 0.92-10.64 .69
Low ejection fraction, 25% 3.25 0.58-6.58 .02
Contralateral carotid occlusion 1.68 0.64-6.19 .98
Prior ipsilateral CEA 0.21 0.12-0.69 .001
Lesion involves carotid bulb 1.86 1.10-2.56 .09
History of smoking 2.36 1.26-5.25 .08
OR, Odds ratio; CI, confidence interval; CEA, carotid endarterectomy.In this study, we found that hemodynamic depressionoccurred in 46% of patients undergoing CAS procedures.
Risk-factors analysis showed that predisposing conditions
associated with hemodynamic instability included ad-
vanced age and low ejection fraction. Our study also
showed that persistent hypotension, not hypotension
alone, is associated with an increased risk of adverse clinical
outcome. We postulate the latter finding is likely due to the
poor tolerance of persistent hemodynamic depression in
cohorts of elderly patients because cardiopulmonary ad-
verse clinical events were the main culprit of their non-
neurologic complications (Table III).
The frequency of CAS-induced bradycardia and hypo-
tension in our series was 27% and 14%, respectively, and the
incidence of combined bradycardia and hypotension was
5%. The reported incidence of CAS-induced bradycardia
varies widely in the literature, from 5% to 76%.6-13 The
incidence of hypotension during CAS also ranges widely,
from 14% to 28%, based on available reports.6-13
We postulate that this wide range of heart rate and
blood pressure fluctuations may be partly due to inconsis-
tency of hemodynamic definitions used in various clinical
reports. We defined hypotension as a decrease of baseline
systolic blood pressure by 30 mm Hg after carotid inter-
vention, which is a definition others have used when ana-
lyzing hemodynamic disturbances after surgical carotid re-
construction.8 We further defined persistent hypotension
as blood pressure reduction lasting 1 hour. This variable
correlates with adverse clinical outcome in our series, a
finding that has been supported by others.6,12
Dangas et al6 reported that persistent hypotension is
more likely to occur after balloon-expandable stenting than
after self-expanding stenting, a phenomenon likely due to
augmented carotid sinus stimulation by the balloon-
expandable stents. Furthermore, persistent hypotension
correlated with increased in-hospital complications and
long-term risk of death in their series. The clinical signifi-
cance of CAS-induced hypotension was also highlighted
by a study that showed that blood pressure reduction of
50 mm Hg, rather than the duration of hypotension,
was a predictor of adverse neurologic events after carotid
nd postprocedural complications
mic Patients without persistent hemodynamic
depression (n  374), n (%) P
9 (2) .02
2 (1) .05
2 (1) NS
2 (1) NS
3 (1) .05
6 (2) .05
12 (3) .001
6 (2) .03
3 (1) .05
1 (1) .05
2 (1) .01ion a
odyna
(%)stenting.23
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for hemodynamic depression, our result showed that in-
creased age and low cardiac ejection fraction (25%) were
associated with an increased adjusted risk for hemodynamic
instability after CAS (Table IV). Previous reports have
suggested that increased age represents a risk factor of
neurologic complication after CAS.19,24,25 Our observa-
tion is consistent with other reports that showed elderly
patients and those with coronary disease are at an increased
risk for hemodynamic depression after CAS.9,11
When physicians perform CAS in elderly patients with
age-related cardiac dysfunction, they should be cognizant
that these patients may have depressed cardiac output state
due to low blood volume and compromised diastolic ven-
tricular dysfunction. In the event of carotid baroreceptor
stimulation triggered by balloon angioplasty or stent place-
ment, these patients may not have a full cerebral autoregu-
latory response to bradycardia or hypotension partly due to
age-related neuronal impairment. As a consequence, older
patients or those with compromised cardiac reserve are
vulnerable to hypotensive episodes after CAS. Similar find-
ings have supported that patients with impaired cardiac
function due to coronary artery disease are at an increased
risk for hemodynamic depression after CAS, possibly due to
chronic structural and functional impairment of myocardial
function.9,11
Other researchers have reported that plaques involving
the carotid bulb represent an increased risk for the devel-
opment of hemodynamic depression after CAS.6,12 Gupta
et al12 reviewed the incidence and predictors of bradycardia
and hypotension in 400 consecutive patients. Using a mul-
tivariate analysis, these authors noted that plaques at the
carotid bifurcation and calcified or ulcerated plaques were
associated with a significantly higher risk of hemodynamic
instability.6,12
The association of hemodynamic depression and ca-
rotid plaque characteristics was similarly demonstrated by
Leisch et al,26 who reported that transient asystole and
hypotension developed in 40% of their patients. That study
also showed that the most important predictor of hemody-
namic instability was a lesion involving the carotid bifurca-
tion and that carotid plaque characteristics that were asso-
ciated with CAS-related hypotension included an ostial
lesion and isolated internal carotid artery calcification.26
Contrary to their findings, our results did not demonstrate
that carotid plaque characteristics were related to either
CAS-induced hemodynamic depression or post-CAS com-
plications.
Gupta et al12 reported interesting findings that diabetes
mellitus and a history of smoking reduced the risk of
hemodynamic instability after CAS.12 They postulated that
long-term smoking impairs the carotid baroreceptor re-
sponse and augments the sympathetic tone, which raises
the blood pressure and heart rate.12,27,28 Similarly, diabetes
mellitus is known to impair cardiovascular autonomic re-
sponse by attenuating parasympathetic nerve function,
which may attenuate the carotid baroreceptor stimula-
tion triggered by carotid intervention.29,30 Despite thehigh prevalence of smoking and diabetes in our patient
population of veterans, we were unable to show that
these variables reduced the risk of hemodynamic depres-
sion after CAS.
Patients in our study with prior CEA-related carotid
stenosis constituted 23% of those who underwent CAS
procedure, and hemodynamic depression was less likely to
develop in these patients after CAS (OR, 0.21; 95% CI,
0.12 to 0.69; P  .001; Table IV), a finding that has been
supported by others.8,9,11 The adventitial baroreceptors
located in the carotid sinus plays a critical role in hemody-
namic alterations during and after CAS. Impulses originat-
ing in the carotid sinus reach the medullary vasomotor
nuclei by way of the carotid sinus nerve and the glossopha-
ryngeal nerve. Distension of the carotid bulb by means of
balloon angioplasty or stent placement leads to barorecep-
tor stimulation that not only triggers a reflex inhibition of
adrenergic output which reduces peripheral sympathetic
tones but also increases parasympathetic activity, which
ultimately leads to hypotension and bradycardia.11,31
In patients who have had a prior CEA, either the
carotid sinus or the carotid sinus nerve, which lies in the
vicinity of the carotid bulb, has been routinely divided or
interrupted surgically. As the result, the carotid adventitial
baroreceptors or the afferent nerve fibers are unable to send
impulses to the medulla when triggered by balloon dilata-
tion, which likely accounts for the low incidence of CAS-
induced bradycardia in patients with post-CEA carotid
stenosis.
The impact of hemodynamic alteration triggered by
nerve interruption during CEA was also highlighted by
Mehta et al,32 who reported a higher incidence of hyper-
tension after eversion endarterectomy. They attributed the
CEA-associated hypertension to the loss of the barorecep-
tor reflex secondary to nerve injury caused by carotid bulb
transection during an eversion endarterectomy.32 They
also reported a decreased need for perioperative vasopres-
sors in patients whose carotid sinus nerve had been divided.
The ideal treatment of CAS-related bradycardia and
hypotension remains a subject of debate. We administered
intravenous atropine only when bradycardia was triggered
by carotid instrumentation. We have modified our clinical
practice during the CAS procedure such that a nurse will
call out the heart rate on the basis of an electrocardiogram
tracing during carotid balloon angioplasty or carotid stent
deployment. This clinical practice allows the staff physicians
to remain focused on the fluoroscopic monitor while re-
ceiving an audible feedback on the patient’s heart rate and
enables a clear communication among all personnel about
the decision of atropine administration. Although we have
reported a potential adjunctive role of temporary trans-
femoral cardiac pacing to treat bradycardia during CAS,33
we have found that prompt atropine administration in
selective cases is effective in reversing CAS-induced brady-
cardia.
In contrast, other physicians have advocated prophylac-
tic atropine administration in all patients undergoing
CAS.5,26 It should be emphasized that prophylactic treat-
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Qureshi et al11 reported a paradoxical finding of a higher
risk of postprocedural bradycardia associated with prophy-
lactic use of atropine in patients undergoing CAS. Other
side effects of atropine include tachycardia, confusion, uri-
nary retention, and arrhythmias.34,35 With resultant tachy-
cardia and arrhythmia, there is an increased cardiac oxygen
demand and added myocardial workload that may lead to
adverse cardiac events, particularly because many of these
patients are elderly and have underlying coronary artery
disease.
Our study has several limitations that are related to its
retrospective nature as well as potential patient selection
and treatment bias. However, an established criteria was
used for patient selection, and our treatment approach
adhered to a strict technical protocol that was reported
previously.4,16-18 As a consequence, we do not believe our
findings are significantly influenced by any bias.
All of our procedures were performed in the operating
room, and the patients were monitored by an anesthesiol-
ogist who provided anxiolytic drugs at his or her clinical
discretion. Because a standardized protocol was not use for
the administration of anxiolytic medications, these drugs
may have influenced the heart rate and blood pressure
response in our patients.
Finally, we recognize that this series represents a single-
center experience that took place at a Veterans Affairs
Medical Center. Nearly all patients were men, which pre-
cluded an impartial assessment of the role of gender in the
hemodynamic alteration after the CAS procedure.
CONCLUSION
Our study has shown that hemodynamic fluctuation
during CAS is a frequent phenomenon. Patients with
postendarterectomy carotid stenosis are protected from the
development of hemodynamic depression, and elderly pa-
tients and those with poor cardiac function are at risk.
Because persistent hemodynamic depression is associated
with adverse clinical outcome, prompt pharmacologic
treatment with appropriate fluid resuscitation should be
considered. Further studies are warranted to better predict
patients at risk of developing this physiologic response as
well as developing a treatment strategy to prevent hemody-
namic instability in an effort to reduce CAS-associated
adverse clinical events.
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DrCarlos Timaran (Dallas, Tex). Dr Lin and colleagues have
presented an important study about a problem that is being seen
more frequently by vascular surgeons as we embrace carotid angio-
plasty and stenting (CAS). As shown in this study, CASmay induce
bradycardia and hypotension that may be associated with adverse
outcomes if not resolved expeditiously. CAS-induced bradycardia
is typically short lived, whereas hypotension is more persistent.
Because CAS is currently reserved primarily for high-risk patients,
hemodynamic changes could potentially result in significant mor-
bidity and mortality, particularly in patients with severe cardiovas-
cular disease. Moreover, this study has revealed that elderly pa-
tients and those with severely depressed cardiac function are at
higher risk of developing CAS-induced hemodynamic depression.
Based on the results of the current study, I have the following
comments and questions:
First, in the multivariate logistic regression models included in
your paper, age groups were analyzed rather than age as a contin-
uous variable. This is a rather unfortunate, as most statisticians
would agree that continuous variables should be maintained con-
tinuous. Did you analyze age as a continuous variable in separate
models? If you did, what is the age cutoff value above which the
risk of hemodynamic changes is more significant? It appears that
octogenarians have the highest risk in this series. Do you believe
that because of this additional risk factor, CAS should definitely be
avoided in octogenarians?
Second, in this series, CAS-induced bradycardia was treated
with atropine and hypotension with dopamine. The use of atropine
during CAS is controversial as it has significant side effects, partic-
ularly in elderly and high-risk patients, including mental status
changes and persistent tachycardia that may lead to myocardial
ischemia. Dopamine, on the other hand, can also induce tachycar-
dia and arrhythmias and its mechanism of action does not treat the
physiologic changes induced by stretching the carotid sinus.More-
over, because atropine and dopamine produce tachycardia through
different mechanisms, their actions could be additive even syner-
gistic. What was the incidence of persistent hypertension or tachy-
cardia related to the use of atropine and dopamine? What was the
incidence of treatment-induced arrhythmias, angina and myocar-
dial infections?
Third, atropine is rarely used these days as an adjunct to
general anesthesia because of its serious adverse effects. Glycopyr-of its limited half-life. Why haven’t the authors used it instead of
atropine? What do the authors think about using vasopressors with
mechanisms of action that have more physiologic basis for the
treatment of CAS-induced hypotension, such as ephedrine and
norepinephrine.
Finally, I would like your input regarding a patient I had to
treat several weeks ago. This was an 81-year-old patient with
symptomatic carotid stenosis, unstable angina, 80% stenosis of the
left main, and 99% stenosis of the right coronary arteries. His
ejection fraction was 25%. According to your data, this patient has
a high risk of adverse outcome. How would you treat this patient
considering that his coronary artery disease was deemed nonrecon-
structable? I may consider transferring patients like this to Hous-
ton if you have the right answer.
I want to thank the authors for sending me their manuscript in
advance and the association for the honor of discussing this impor-
tant study and the privilege of the floor.
Dr Peter H. Lin: Regarding your first question, which deals
with the statistical analyses of the age factor as a continuous
variable as well as the categorical variable, we did perform analysis
using age as a continuous variable and similarly discovered that
increased age was associated with an increased risk of hemody-
namic depression.
With that said, I think it is premature to draw a conclusion
based on this study to say that carotid stenting is indeed contrain-
dicated or avoided in elderly patients. There are many factors that
can lead to the development of bradycardia or hypotension in
elderly patients. One potential issue that comes to my mind is that
many of these octogenarian patients are perhaps hypovolemic;
particularly, many of these patients may have underlying left ven-
tricular dysfunction, whichmay lower the threshold of sympathetic
activation. As such, elderly patients who are dehydrated with
suppressed cardiac function are more likely to develop hemody-
namic depression following baroreceptor stimulation. One learn-
ing point that we can draw from our experience is that interven-
tionalists should have a higher level of awareness when performing
carotid stenting in elderly patients who might have compromised
cardiac function. These patients should be appropriately hydrated
during this procedure to reduce the likelihood of postprocedural
hypotension or carotid sinus activation.
Your second question relates to the use of atropine and
dopamine. In our practice, we only administer intravenous atro-
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selective atropine administration is very effective in reversing
carotid-stenting-induced bradycardia. I do want to point out a
technical step in our practice with regards to atropine administra-
tion. Whenever we are about to perform balloon dilation of the
carotid artery or deploy a carotid stent, we have an OR nurse or
nurse anesthetist read the heart rate loudly in the operating room
so that everyone in the operating room can receive an audible
readout of the heart rate. The decision of atropine administration is
clearly communicated with everyone participating in the stenting
procedures, including the surgeons, anesthesiologists, nurses, res-
idents, and even medical students. In no instance do we have to
administer additional atropine once patients leave the operating
room. I do have to emphasize that we have the advantage because
all carotid stenting procedures were done in the operating room
with staff anesthesiology monitoring, and we have been very
satisfied with added staff support in the way these patients are
monitored.
With regards to your third question, we do not have experi-
ence with glycopyrrolate to treat patients with bradycardia. Addi-
tionally, we have not experience any side effects of atropine,
although we fully recognize that this drug can cause hypotension,
particularly in patients who are hypovolemic. With that said, our
treatment approach in patients who developed post-stenting hy-potension is to provide fluid resuscitation first. After a liter or so of
fluid, which obviously depends on the patient’s cardiac function,
we will put a central line in to monitor their intravenous pressure
and follow-up by appropriate vasopressor agent administration.
With regard to your last question of an 80-year old gentleman
with increased cardiac morbidities, clearly it is difficult to answer
that question based on brief history. However, I do think that
carotid endarterectomy under local anesthesia remains an excellent
treatment option even in high-risk patients with carotid artery
stenosis. I was fortunate to receive my vascular surgery fellowship
training at Emory University School of Medicine where I learned
the art of carotid endarterectomy under local anesthesia from
surgeons such as Drs Bob Smith, Atef Salamn, Tom Dodson, and
Eliot Chaikof. To this date, I continue to perform carotid endar-
terectomy under local anesthesia in my practice. In patients who
have anatomical concern to undergo carotid stenting, we have
shown in our experience that carotid endarterectomy under local
anesthesia is clearly an excellent treatment option even in elderly
patients. Therefore based on the scenario you provided, I would
consider both options in the overall treatment strategy. The car-
diac comorbidities that you had mentioned would not preclude
this patient from undergoing carotid endarterectomy under local
anesthesia.
